Krishna Baksi to Tunicamycin
This is a "connection" page, showing publications Krishna Baksi has written about Tunicamycin.
Connection Strength
0.607
-
Banerjee DK, Seijo Lebr?n A, Baksi K. Glycotherapy: A New Paradigm in Breast Cancer Research. Biomolecules. 2022 03 23; 12(4).
Score: 0.208
-
Banerjee A, Martinez JA, Longas MO, Zhang Z, Santiago J, Baksi K, Banerjee DK. N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeutic. Adv Exp Med Biol. 2015; 842:355-74.
Score: 0.126
-
Banerjee A, Lang JY, Hung MC, Sengupta K, Banerjee SK, Baksi K, Banerjee DK. Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin. J Biol Chem. 2011 Aug 19; 286(33):29127-29138.
Score: 0.099
-
Banerjee DK, Oliveira CM, Tav?rez JJ, Katiyar VN, Saha S, Mart?nez JA, Banerjee A, S?nchez A, Baksi K. Importance of a factor VIIIc-like glycoprotein expressed in capillary endothelial cells (eFactor VIIIc) in angiogenesis. Adv Exp Med Biol. 2011; 705:453-64.
Score: 0.096
-
Serrano-Negr?n JE, Zhang Z, Rivera-Ruiz AP, Banerjee A, Romero-Nutz EC, S?nchez-Torres N, Baksi K, Banerjee DK. Tunicamycin-induced ER stress in breast cancer cells neither expresses GRP78 on the surface nor secretes it into the media. Glycobiology. 2018 02 01; 28(2):61-68.
Score: 0.039
-
Zhang Z, Serrano-Negr?n JE, Mart?nez JA, Baksi K, Banerjee DK. Dynamic Function of DPMS Is Essential for Angiogenesis and Cancer Progression. Adv Exp Med Biol. 2018; 1112:223-244.
Score: 0.039